A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

NCT02424253 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: ZPL-3893787
DRUG: Placebo

Sponsor

Ziarco Pharma Ltd